Alnylam Pharmaceuticals
ALNY
#570
Rank
C$59.48 B
Marketcap
C$445.80
Share price
0.26%
Change (1 day)
35.14%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company